Poly Medicure Limited has informed the Exchange regarding Board meeting held on November 08, 2025 for declaration of Unaudited Financial Statements (Standalone & Consolidated) for the Second quarter and half year ended 30th September, 2025 and for other businesses item.
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Poly Medicure Limited has informed the exchanges that its Board of Directors met on November 08, 2025 and approved the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025. The Board also considered other business items during the meeting. This is a standard regulatory disclosure confirming that results have been approved, with no specific numbers or figures shared in this filing.
The actual financial numbers are not disclosed in this announcement, so there is no direct stock price impact. Investors should look for the detailed results filing for revenue, profit, and margin figures to assess performance.